45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,287
Insurances with rates
14
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 12568012_1 | INJECTION, INEBILIZUMAB-CDON, 1 MG | $123,386 | $98,709 | — | — | 16 |
| 11660583_1 | INJECTION, OCRELIZUMAB, 1 MG | $54,063 | $43,250 | — | — | 16 |
| 12629526_1 | INJECTION, CANAKINUMAB, 1 MG | $48,532 | $38,826 | — | — | 16 |
| 12103390_1 | Removal and replacement of multiple lead defibrillator | $48,053 | $38,442 | — | — | 16 |
| 12103383_1 | PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF CHRONIC TOTAL OCCLUSION, CORONARY ARTERY, CORONARY AR | $42,906 | $34,325 | — | — | 15 |
| 12469716_1 | INJECTION, POLATUZUMAB VEDOTIN-PIIQ, 1 MG | $39,818 | $31,854 | — | — | 16 |
| 5551578_1 | CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER (IMPLANTABLE) | $37,585 | $30,068 | — | — | 15 |
| 5551576_1 | CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER (IMPLANTABLE) | $37,320 | $29,856 | — | — | 15 |
| 5551579_1 | CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE) | $36,721 | $29,377 | — | — | 15 |
| 12103336_1 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $36,329 | $29,063 | — | — | 16 |
| 5551577_1 | CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER (IMPLANTABLE) | $35,970 | $28,776 | — | — | 15 |
| 12667828_1 | INJECTION, GUSELKUMAB, 1 MG | $34,960 | $27,968 | — | — | 16 |
| 5375134_1 | INJECTION, LANREOTIDE, 1 MG | $34,423 | $27,539 | — | — | 16 |
| 10806578_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $34,014 | $27,211 | — | — | 15 |
| 12100544_1 | Insertion of implantable defibrillator system | $33,680 | $26,944 | — | — | 16 |
| 12103387_1 | Insertion of implantable defibrillator system | $33,680 | $26,944 | — | — | 16 |
| 12100548_1 | Removal and replacement of single lead defibrillator | $33,049 | $26,439 | — | — | 16 |
| 5551580_1 | CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE) | $32,258 | $25,806 | — | — | 15 |
| 12145922_1 | INJECTION, LANREOTIDE, (CIPLA), 1 MG | $32,014 | $25,611 | — | — | 16 |
| 12713994_1 | JOINT DEVICE (IMPLANTABLE) | $29,020 | $23,216 | — | — | 15 |
| 12709403_1 | JOINT DEVICE (IMPLANTABLE) | $28,400 | $22,720 | — | — | 15 |
| 12103158_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $28,288 | $22,630 | — | — | 16 |
| 12100579_1 | PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF OR THROUGH CORONARY ARTERY BYPASS GRAFT (INTERNAL MAM | $27,020 | $21,616 | — | — | 16 |
| 12103382_1 | PERCUTANEOUS TRANSLUMINAL REVASCULARIZATION OF CHRONIC TOTAL OCCLUSION, CORONARY ARTERY, CORONARY AR | $26,900 | $21,520 | — | — | 16 |
| 10806576_1 | CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER (IMPLANTABLE) | $26,366 | $21,093 | — | — | 15 |
| 5551574_1 | CARDIOVERTER-DEFIBRILLATOR, OTHER THAN SINGLE OR DUAL CHAMBER (IMPLANTABLE) | $26,100 | $20,880 | — | — | 15 |
| 4907442_1 | INJECTION, IPILIMUMAB, 1 MG | $25,598 | $20,478 | — | — | 16 |
| 12559254_1 | INJECTION, UBLITUXIMAB-XIIY, 1MG | $25,134 | $20,107 | — | — | 16 |
| 12445872_1 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $24,885 | $19,908 | — | — | 16 |
| 12629523_1 | INJECTION, IMETELSTAT, 1 MG | $24,433 | $19,547 | — | — | 16 |
| 10806577_1 | CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER (IMPLANTABLE) | $23,733 | $18,986 | — | — | 15 |
| 12100538_1 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or b | $23,439 | $18,751 | — | — | 16 |
| 5469650_1 | INJECTION, VEDOLIZUMAB, INTRAVENOUS, 1 MG | $23,318 | $18,654 | — | — | 16 |
| 4595414_1 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $23,180 | $18,544 | — | — | 16 |
| 6072571_1 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $23,105 | $18,484 | — | — | 16 |
| 8540571_1 | INJECTION, OBINUTUZUMAB, 10 MG | $22,606 | $18,085 | — | — | 16 |
| 12709400_1 | JOINT DEVICE (IMPLANTABLE) | $22,000 | $17,600 | — | — | 15 |
| 12709383_1 | JOINT DEVICE (IMPLANTABLE) | $21,500 | $17,200 | — | — | 15 |
| 10348571_1 | INJECTION, BENRALIZUMAB, 1 MG | $21,049 | $16,840 | — | — | 16 |
| 12100116_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $20,787 | $16,630 | — | — | 16 |
| 12104669_1 | REVASCULARIZATION, ENDOVASCULAR, OPEN OR PERCUTANEOUS, ILIAC VASCULAR TERRITORY, WITH TRANSLUMINAL S | $20,586 | $16,469 | — | — | 16 |
| 4681377_1 | INJECTION, NATALIZUMAB, 1 MG | $20,491 | $16,392 | — | — | 16 |
| 4881556_1 | JOINT DEVICE (IMPLANTABLE) | $20,234 | $16,187 | — | — | 15 |
| 4881555_1 | JOINT DEVICE (IMPLANTABLE) | $20,232 | $16,186 | — | — | 15 |
| 12130629_1 | INJECTION, LUSPATERCEPT-AAMT, 0.25 MG | $20,051 | $16,041 | — | — | 16 |
| 12671465_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $19,797 | $15,838 | — | — | 15 |
| 12104652_1 | Occlusion of growths or obstructed vessels with review by radiologist | $19,688 | $15,750 | — | — | 16 |
| 12113079_1 | INJECTION, NIVOLUMAB, 1 MG | $19,505 | $15,604 | — | — | 16 |
| 12710913_1 | MESH (IMPLANTABLE) | $19,351 | $15,481 | — | — | 15 |
| 12103442_1 | Insertion of stent in artery (except lower extremity, chest, heart, neck and brain) with review by r | $19,272 | $15,418 | — | — | 16 |
Showing top 50 of 14,287 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.